Purified anti-human CD255 (TWEAK)

TNF-like weak inducer of apoptosis (TWEAK) is a type II transmembrane TNF superfamily member with strong homology to TNF in its extracellular portion, though less potent in inducing apoptosis. It has been clustered as CD255. TWEAK transcript is expressed broadly in many adult and fetal tissues; however, the staining of human peripheral blood mononuclear cells with TWEAK-specific antibodies shows a more restricted pattern. TWEAK is expressed as membrane-bound and secreted forms. Interaction of TWEAK with its receptors (DR3, Fn14) promotes secretion of IL-8, activation of NF-kappaB, proliferation of endothelial cells, and apoptosis in a number of human cell lines. The CARL-2 antibody can neutralize the bioactivity of natural or recombinant TWEAK.

Prices direct from BioLegend

Quick response times

Exclusive Biosave savings/discounts

SPECIFICATIONS

Catalog Number

308402

Size

100 microg

Applications

FC

Hosts

Mouse

Reactivities

Hum

Clone

CARL-2

Antigen

hTWEAK/2PK-3 transfectant cells

Gene Id

8472

Isotype

Mouse IgM, kappa

Clonality

Monoclonal

Dilutions

Each lot of this antibody is quality control tested by sandwich ELISA. For ELISA capture applications, a concentration range of 1-4 microg/ml is recommended. It is recommended that the reagent be titrated for optimal performance for each application.

Storage Temp

4 C

Concentration

0.5 mg/ml

Shipping Temp

Ambient RT

Storage Buffer

The antibody solution should be stored undiluted at 4C.

Alternative Names

TNF-like weak inducer of apoptosis, Apo-3 ligand, DR3-L, TNFSF-12

Regulatory Status

RUO